Español (soon!) - March 10, 2010
CME on Transplantation is dedicated to online CME conferences, courses and presentations (slides with voice over) on transplantation, given by local and international experts. Its mission is to keep you up-to-date with the most recent developments on transplantation.
 Presentation
"Chronic Kidney Disease in Heart, Liver and Lung Transplant Recipients"
Dr. Akinlolu O. Ojo (biography)
English - 2004-11-26 - 47 minutes
(34 slides)

Summary :
The modern immunosuppressive era has resulted in a significantly increased life-expectancy for solid organ transplant recipients. However, as a result of this, combined with the nephrotoxic potential of calcineurin inhibitors (CNI), chronic kidney disease (CKD) is increasingly an increasingly common complication of solid organ transplantation. Here, Dr. Akinlolu Ojo reviews his findings on the incidence of CKD among non-renal transplant recipients in the UNOS transplant registry.

Are certain transplant populations at higher risk of CKD than others? What is the cost of CKD in our transplant patients? What is the contribution of CNI to the risk of CKD post-transplant and how can we alter the immunosuppressive regimen to reduce this risk? Dr. Ojo addresses these questions and more in this superb comprehensive review of one of the most important complications of transplantation today.

Copyright © E-MedHosting.com

Learning objectives :
After viewing this presentation, participants will be able to discuss:
• The incidence of chronic kidney disease (CKD) in different solid organ transplant populations
• The financial and morbidity and mortality cost of CKD
• The relative contribution of both pre- and post-transplant factors to the risk of CKD
• The effect of CNI elimination on renal dysfunction and CKD

Bibliographic references :
Greenberg A, Egel JW, Thompson ME, Hardesty RL, Griffith BP, Bahnson HT, Bernstein RL, Hastillo A, Hess ML, Puschett JB. Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients. Am J Kidney Dis. 1987 Jan;9(1):12-22.

Zaltzman JS, Pei Y, Maurer J, Patterson A, Cattran DC. Cyclosporine nephrotoxicity in lung transplant recipients. Transplantation. 1992 Nov;54(5):875-8.

McCauley J, Van Thiel DH, Starzl TE, Puschett JB. Acute and chronic renal failure in liver transplantation. Nephron. 1990;55(2):121-8.

National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chsonic Kidney Disease: Evaluation, Classification, and Stratification. Am J Kidney Dis. 39 (2). 2002.

Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003 Sep 4;349(10):931-40.

Paramesh AS, Roayaie S, Doan Y, Schwartz ME, Emre S, Fishbein T, Florman S, Gondolesi GE, Krieger N, Ames S, Bromberg JS, Akalin E. Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease. Clin Transplant. 2004 Feb;18(1):94-9.

Bernardini J, Piraino B, Kormos RL. Patient survival with renal replacement therapy in heart transplantation patients. ASAIO J. 1998 Sep-Oct;44(5):M546-8.

English J, Evan A, Houghton DC, Bennett WM. Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation. 1987 Jul;44(1):135-41.

Griffiths MH, Crowe AV, Papadaki L, Banner NR, Yacoub MH, Thompson FD, Neild GH. Cyclosporin nephrotoxicity in heart and lung transplant patients. QJM. 1996 Oct;89(10):751-63.

Coopersmith CM, Brennan DC, Miller B, Wang C, Hmiel P, Shenoy S, Ramachandran V, Jendrisak MD, Ceriotti CS, Mohanakumar T, Lowell JA. Renal transplantation following previous heart, liver, and lung transplantation: an 8-year single-center experience. Surgery. 2001 Sep;130(3):457-62.

Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment.Transplantation. 2001 Dec 27;72(12):1934-9.

Nair S, Eason J, Loss G. Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients. Liver Transpl. 2003 Feb;9(2):126-9.

Snell GI, Levvey BJ, Chin W, Kotsimbos T, Whitford H, Waters KN, Richardson M, Williams TJ. Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment. J Heart Lung Transplant. 2002 May;21(5):540-6.

Groetzner J, Meiser B, Landwehr P, Buehse L, Mueller M, Kaczmarek I, Vogeser M, Daebritz S, Ueberfuhr P, Reichart B. Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure.Transplantation. 2004 Feb 27;77(4):568-74.

Kassirer JP. Clinical evaluation of kidney function--glomerular function. N Engl J Med. 1971 Aug 12;285(7):385-9.

Myers BD. Cyclosporine nephrotoxicity. Kidney Int. 1986 Dec;30(6):964-74.

   


  Login

  Please enter your username and password to access all the resources CMEonTransplantation.com has to offer.
 
Already a member?
  Username :
  Password :
   
 
  Lost your password?


  Search our database

  Would you like to know more about transplantation? Find what you are looking for by typing a keyword !
  Look for : 
 
  In...  
 
 

  Read our newsletters

  Newsletter 1 (2004-04-08)
C-Reactive Protein (CRP)